2) Rijken DC, Lijnen HR: New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost 7: 4-13, 2009.
3) Foley JH, Kim PY, Mutch NJ, Gils A: Insights into thrombin activatable fibrinolysis inhibitor function and regulation. J Thromb Haemost 11 Suppl 1:306-315, 2013.
4) Marx PF, Brondijk TH, Plug T, Romijn RA, Hemrika W, Meijers JC, Huizinga EG: Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation. Blood 112: 2803-2809, 2008.
5) Anand K, Pallares I, Valnickova Z, Christensen T, Vendrell J, Wendt KU, Schreuder HA, Enghild JJ, Avilés FX: The crystal structure of thrombin-activable fibrinolysis inhibitor (TAFI) provides the structural basis for its intrinsic activity and the short half-life of TAFIa. J Biol Chem 283: 29416-29423, 2008.